Clinical evaluation of fullerene-C 60 dissolved in squalane for anti-wrinkle cosmetics

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 10, 2010, Pages 6769-6774

  Kato, Shinya ^a   Taira, Hikam ^b   Aoshima, Hisae ^b   Saitoh, Yasukazu ^a   Miwa, Nobuhiko ^a  

^a PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^b Vitamin C60 BioResearch Corporation   (Japan)

Author keywords

Anti wrinkle formation; Double blind study; Fullerene C 60; Squalane

Indexed keywords

ACTIVE INGREDIENTS; AREA RATIOS; CLINICAL EVALUATION; COSMETIC INGREDIENTS; DOUBLE-BLIND STUDY; INSTRUMENTAL ANALYSIS; MOISTURE LEVEL; OLIVE OIL; OPTICAL PROFILOMETRY; SATURATED CONCENTRATIONS; SIDE EFFECT; SKIN MOISTURE; SQUALANE; STRATUM CORNEUM; VISUAL OBSERVATIONS; WATER LOSS; WRINKLE FORMATION;

ELASTICITY; MOISTURE; ORGANIC SOLVENTS; PHOTOGRAPHY; SILICONES; SURFACE ROUGHNESS; VEGETABLE OILS;

FULLERENES;

COSMETIC; DRUG DERIVATIVE; FULLERENE C60; FULLERENE DERIVATIVE; OLIVE OIL; SQUALANE; SQUALENE; VEGETABLE OIL;

ADULT; ARTICLE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; PHOTOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; COSMETICS; DOUBLE-BLIND METHOD; FEMALE; FULLERENES; HUMANS; PHOTOGRAPHY; PLANT OILS; SKIN; SKIN AGING; SQUALENE;

EID: 79952199934     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.3053     Document Type: Article

References (22)

1. H. W. Kroto, J. R. Heath, S. C. O'Brien, R. F. Curl, and R. E. Smalley, Nature 318, 162 (1985).
2. P. J. Krusic, E. Wasserman, P. N. Keizer, J. R. Morton, and K. F. Preston, Science 254, 1183 (1991).
3. D. Harman, J. Gerontol. 11, 298 (1956).
4. H. S. Black, Photochem. Photobiol. 46, 213 (1987).
5. M. Lens, Recent Pat. Biotechnol. 3, 118 (2009).
6. S. S. Ali, J. I. Hardt, K. L. Quick, J. S. Kim-Han, B. F. Erlanger, T. T. Huang, C. J. Epstein, and L. L. Dugan, Free Radic. Biol. Med. 37, 1191 (2004).
7. S. S. Ali, J. I. Hardt, and L. L. Dugan, Nanomedicine 4, 283 (2008).
8. L. Gan, S. Huang, X. Zhang, A. Zhang, B. Cheng, H. Cheng, X. Li, and G. Shang, J. Am. Chem. Soc. 124, 13384 (2002).
9. N. Komesvarakul, M. D. Sanders, E. Szekeres, E. J. Acosta, J. F. Faller, T. Mentlik, L. B. Fisher, G. Nicoll, D. A. Sabatini, and J. F. Scamehom, J. Cosmet. Sci. 57, 309 (2006).
10. S. Kato, H. Aoshima, Y. Saitoh, and N. Miwa, J. Biomed. Nanotechnol. 6, 52 (2010).
11. T. Kaneko, S. Honda, S. Nakano, and M. Matsuo, Chem. Biol. Interact. 63, 127 (1987).
12. Task Force Committee for Evaluation of Anti-Aging Function Guidelines for Evaluation of Anti-Wrinkle Products, J. Japanese Cosmetic Sci. Soc. 31, 411 (2007).
13. H. Aoshima, Y. Saitoh, S. Ito, S. Yamana, and N. Miwa, J. Toxicol. Sci. 34, 555 (2009).
14. N. Hayashi, K. Togawa, M. Yanagisawa, J. Hosogi, D. Mimura, and Y. Yamamoto, Exp. Dermatol. 12, 13 (2003).
15. A. Pines and C. Backendorf, Methods Mol. Biol. 585, 45 (2010).
16. L. Xiao, H. Takada, K. Maeda, M. Haramoto, and N. Miwa, Biomed. Pharmacother. 59, 351 (2005).
17. L. Xiao, H. Takada, X. Gan, and N. Miwa, Bioorg. Med. Chem. Lett. 16, 1590 (2006).
18. S. Kato, H. Aoshima, Y Saitoh, and N. Miwa, Basic Clin. Pharmacol. Toxicol. 104, 483 (2009).
19. H. Knaggs, J. Cosmet. Dermatol. 8, 77 (2009).
20. M. Darvin, L. Zastrow, W. Sterry, and J. Lademann, Skin Pharmacol. Physiol. 19, 238 (2006).
21. C. Flynn and B. A. McCormack, J. Biomech. 43, 442 (2010).
22. M. E. Parente, A. Gambaro, and G. Solana, J. Cosmet. Sci. 56, 175 (2005).